1
Richard E. Anderson, MD, FACP Chairman and Chief Executive Officer
Executive Member Advisory Richard E. Anderson, MD, FACP August 13, - - PDF document
Chairman and Chief Executive Officer 1 Executive Member Advisory Richard E. Anderson, MD, FACP August 13, 2009 Board Introduction We have reached the inflection point of the current market cycle Evidence Implications and
1
Richard E. Anderson, MD, FACP Chairman and Chief Executive Officer
2
3
20.0 30.0 40.0 50.0 60.0 70.0 80.0 90.0 100.0 110.0 120.0 130.0 140.0 150.0 160.0 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007
Year Ratio
Calendar-year Loss Ratio Investment Ratio
HARD MARKET HARD MARKET SOFT MARKET SOFT Source: Best’s Aggregates and Averages 7/18/2008
4
5
6
TDC Claims Per 100 Mature, FTE Doctors
17.9 17.9 17.6 17.7 12.6 10.7 10.2 9.7 10.0 11.2 0.0 2.0 4.0 6.0 8.0 10.0 12.0 14.0 16.0 18.0 20.0 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 Report Year Data evaluated as of 3/31/09
7
TDC PHYSICIAN SEVERITY (Gross of Deductibles) NATIONWIDE
20 40 60 80 100 120 2002 2003 2004 2005 2006 2007 2008 Report Year 5.8% Annual Trend Rate
8
% Change in Average Loss Compared to Prior Year
0% 10% 20% 30% 40% 1 9 8 9 1 9 9 1 9 9 1 1 9 9 2 1 9 9 3 1 9 9 4 1 9 9 5 1 9 9 6 1 9 9 7 1 9 9 8 1 9 9 9 2 2 1 2 2 2 3 2 4 2 5 2 6 2 7 2 8
Closing Year Severity significantly different than expected in half the years 10 Points Above Mean 10 Points Below Mean Mean +8%
9
TDC Group – Investment Yield (Including Realized & Unrealized Capital Gains & Losses)
7.3% 5.7% 4.1% 4.9% 2.4% 5.8% 1.2% 5.0% 4.9%
1.0% 3.0% 5.0% 7.0% 9.0% '99 '00 '01 '02 '03 '04 '05 '06 '07 '08
10
11
– Flat since 2005 and probably heading upward
– Has moved upward by 5% - 6% annually over a long term – BUT annual levels very difficult to predict
– Large rate increases in 2002 – 2003 – Moderated in 2004 – 2005 – Stable or downward since 2006
12
– Regulators no longer recognize industry need to rebuild financial strength – No additional tort reform likely in near future
– Subsidization of rates must decrease
13
14
Written Price Changes Evaluated as of 3/31/09
25% 12% 4%
24%
0% 5% 10% 15% 20% 25% 30% 2002 2003 2004 2005 2006 2007 2008 2009
15
$124 $21 $23 $- $20 $40 $60 $80 $100 $120 $140 1976 - 1995 2007 2008 2009 $17
($ Millions)
16 $50,000,000 $325,000 $50,000,000 $406,000 $53,000,000 $50,000,000 $50,000,000 $- $10,000,000 $20,000,000 $30,000,000 $40,000,000 $50,000,000 $60,000,000 2007 2008 2009 2010 2011 Approved Funding Distributed Funding Commitment
Average Tribute Balance at 1/31/09: $3,100 Highest Tribute Balance at 7/31/09: $76,000
17
18
19
20
21
– Pharmaceuticals – Charge what the market will bear
– ~$1,000 per person in U.S. (3.5x Canada)
– High-tech equipment and procedures – Supply drives demand
22
23
24
25
26
27
28
29
30
31
Richard E. Anderson, M.D. Chairman and Chief Executive Officer